Hepatic dysfunction in kidney transplant recipients: Prevalence and impact on graft and patient survival

Clinical and Experimental Nephrology

Volumn 11, Issue 4, 2007, Pages 309-315

  Gheith, Osama A ^a   Saad, Mohamed A ^a   Hassan, Ahmed A ^b   A Eldeeb, Salem ^b   Agroudy, Amgad E El ^a   Sheashaa, Hussein ^a   Ghoneim, Mohamed A ^a  

^a MANSOURA UNIVERSITY   (Egypt)

^b ZAGAZIG UNIVERSITY   (Egypt)

Author keywords

Hepatic dysfunction; Renal allortansplant

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; RAPAMYCIN; TACROLIMUS;

ADULT; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; CYTOMEGALOVIRUS; DIALYSIS; DISEASE COURSE; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFECTION RATE; KIDNEY ALLOGRAFT; KIDNEY GRAFT REJECTION; LIVER DYSFUNCTION; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; PERSISTENT INFECTION; RISK FACTOR; SAMPLE SIZE; TISSUE SECTION;

ADULT; CYTOMEGALOVIRUS INFECTIONS; DIALYSIS; EGYPT; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HEPATITIS B; HEPATITIS C; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVER DISEASES; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 37249080855     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-007-0490-7     Document Type: Article

References (34)

1. Natov B, Pereira JG. Liver disease among renal transplant recipients. In: Morris PJ, editor. Kidney transplantation principles and practice. 5th ed. W.B. Saunders Company; 2001. p. 495-532
2. JM Morales JM Campistol A Andres JL Rodicio 1998 Hepatitis C virus and renal transplantation Curr Opin Nephrol Hypertens 7 177 83
3. A Ojo RA Wolfe LY Agodoa 1998 Prognosis after primary renal transplant failure and beneficial effects of repeat transplantation: multivariate analyses from the United States Renal Data System Transplantation 66 1651 9
4. A Rizivi A Naqvi Z Hussain 1998 Factors influencing graft survival in living-related donor kidney transplantation at a single center Transplant Proc 30 712
5. S Hauraib R al-Rashed A Aldrees M Aljefry M Arif FA Al-Falek 1995 High prevalence of and risk factors for hepatitis C in hemodialysis patients in Saudi Arabia: a need for new dialysis strategies Nephrol Dial Transplant 104 470 4
6. Alter HJ. Chronic consequences of non A, non B hepatitis. In: Seeff LB, Lewis JH, editors Current perspectives in hepatology. New York: Plenum; 1989. 8: p. 83-97
7. F Fabrizi P Martin C Ponticelli 2001 Hepatitis C virus infection and renal transplantation Am J Kidney Dis 38 919 34
8. BJG Pereira AS Levey 1997 Hepatitis C virus infection in dialysis and renal transplantation Kidney Int 51 981 99
9. N Ahsan KV Rao 2002 Hepatobiliary diseases after kidney transplantation unrelated to classic hepatitis virus Semin Dial 15 358 65
10. D Van Thiel A Nadir N Shah 2002 Hepatitis C virus and renal transplantation Transplant Proc 34 2433 5
11. F Besisik MS Sever D Dincer U Cevikbas S Turkoglu Y Cakaloglu 2000 Serial measurements of serum transaminases in renal transplant recipients with chronic hepatitis C: do they reflect disease severity? Clin Transplant 14 529 32
12. M Weir T Kirkman T Strom N Tilney 1985 Liver disease in recipients of long functioning renal allograft Kidney Int 28 839
13. U Sharaf El Din M Mansour M Fouad 2003 Five-year experience in kidney transplantation of HCV positive recipients in Egypt African J Nephrology 7 41 51
14. A Aroldi P Lampertico G Montagnino P Passerini M Villa 2005 Natural history of hepatitis B and C in renal allograft recipients Transplantation 79 1132 6
15. IM Mahmoud AF Elhabashi E Elsawy AA El-Husseini GE Sheha MA Sobh 2004 The impact of hepatitis C virus viremia on renal graft and patient survival: a 9-year prospective study Am J Kidney Dis 43 131 9
16. A Bruchfeld H Wilczek C-G ElInder 2004 Hepatitis C infection, time in renal-replacement therapy, and outcome after kidney transplantation Transplantation 78 5
17. MK Breitenfeldt J Rasenack H Berthold M Olschewski J Schroff C Strey WH Grotz 2002 Impact of hepatitis B and C on graft loss and mortality of patients after kidney transplantation Clin Transplant 16 130 6
18. JM Morales B Dominguez-Gil D Sanz-Guajardo J Fernandez F Escuin 2004 The influence of hepatitis B virus infection in the recipient on late renal allograft failure Nephrol Dial Transplant 3 Suppl 72 6
19. C Legendre V Garrigue C Le Bihan MF Mamzer-Bruneel ML Chaix P Landais 1998 Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients Transplantation 65 667 70
20. CT Bock B Buerke HI Tillmann F Tacke V Kliem 2003 Relevance of hepatitis B core gene deletions in patients after kidney transplantation Gastroenterology 124 1809 20
21. KA Kim JS Lee JH Yang YS Moon WJ Lee 2005 Natural history of acute symptomatic hepatitis C in Korea Korean J Gastroenterol 46 10 5 9
22. SN Natov BJ Pereira 1997 Transmission of disease by organ transplantation JR Chapman M Deierhoi C Wight Organ and tissue donation for transplantation Edward Arnold London 120
23. MA Gentil M López F González-Roncero G Rodríguez- Algarra P Pereira R López 2003 Hepatitis C and the incidence of diabetes mellitus after renal transplant: influence of new immunosuppression protocols Transplant Proc 35 1748 50
24. H Knoebler A Stagnaro-Green S Wallenstein M Schwartz SH Roman 1998 Higher incidence of diabetes in liver transplant recipients with hepatitis C J Clin Gastroenterol 26 30 3
25. YA Sens VD Silva P Malafronte JF Souza LA Miorin P Jabur 2004 Posttransplant diabetes mellitus in renal transplant patients with hepatitis C virus Transplant Proc 36 886 8
26. BD Kahan 2000 Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The Rapamune US Study Group Lancet 356 194 202
27. GW Neff P Ruiz JR Madariaga S Nishida M Montalbano D Meyer 2004 Sirolimus-associated hepatotoxicity in liver transplantation Ann Pharmacother 38 1593 6 Epub 2004 Aug 24
28. A Fisher E Mor P Hytiroglou S Emre P Boccagni L Chodoff 1995 FK506 hepatotoxicity in liver allograft recipients Transplantation 59 1631 2
29. B Einollahi B Hajarizadeh S Bakhtiari MR Khatami SM Alavian 2003 Pretransplant hepatitis C virus infection and its effect on the post-transplant course of living renal allograft recipients J Gastroenterol Hepatol 18 836
30. F Fabrizi P Martin V Dixit S Bunnapradist G Dulai 2005 Hepatitis C virus antibody status and survival after renal transplantation: meta-analysis of observational studies Am J Transplant 5 1452 61
31. LX Yu ZP Wang SJ Fu YB Wang CF Du J Xu WF Deng 2004 Hepatitis C virus infection and clinical outcome of kidney transplantation Di Yi Jun Yi Da Xue Xue Bao 24 682 4
32. L Giblin MR Clarkson PJ Conlon JJ Walshe D Hickey 2004 Impaired renal allograft, but not patient survival, in patients with antibodies to hepatitis C virus Ir J Med Sci 173 82 4
33. FN Ozdemir H Micozkadioglu S Sezer Z Arat M Gursoy S Boyacioglu M Haberal 2003 HCV antibody positivity significantly affects renal allograft survival Transplant Proc 35 2701 2
34. HH Lin CC Huang JY Huang CW Yang MS Wu JT Fang 2004 Impact of HCV infection on first cadaveric renal transplantation, a single center experience Clin Transplant 18 261 6